Therapy News and Research

RSS

Viewpoints: Rove renews attack on health law; Calif. 'vaccination crisis'

The disconnect between what Americans think of most provisions of Obamacare (love them!) and what they think of "Obamacare" (hate it!) has been the most perplexing aspect of rollout of the Affordable Care Act.

5 Sep 2014

Researchers demonstrate neuronal effects of novel treatment method for neurological diseases

Tinnitus, migraine, epilepsy, depression, schizophrenia, Alzheimer's: all these are examples of diseases with neurological causes, the treatment and study of which is more and more frequently being carried out by means of magnetic stimulation of the brain. However, the method's precise mechanisms of action have not, as yet, been fully understood.

5 Sep 2014

Researchers investigating new ways to identify drugs against Ebola virus infection

Researchers from the University of Liverpool in collaboration with Public Health England have been investigating new ways to identify drugs that could be used to treat Ebola virus infection.

5 Sep 2014

Keytruda drug gets FDA approval for treatment of advanced melanoma

The U.S. Food and Drug Administration today approved a new immunotherapy drug to treat advanced melanoma, signaling a paradigm shift in the way the deadly skin cancer is treated.

5 Sep 2014

New actinic keratoses data presented at the 15th World Congress of Cancers of the Skin

New data from the international FIELD Study Repeat presented today at the 15th World Congress of Cancers of the Skin (WCCS) in Edinburgh, Scotland, demonstrate initial treatment with Picato® (ingenol mebutate gel) 0.015% is efficacious in treating actinic keratoses (AK) and, when followed by a repeat cycle for persistent and newly emerging AKs, this efficacy is further increased.1 The data also confirm two treatment cycles of Picato® are well tolerated by patients.2

4 Sep 2014

Socio-economic barriers preclude patients from receiving breast conserving therapy

Despite its acceptance as standard of care for early stage breast cancer almost 25 years ago, barriers still exist that preclude patients from receiving breast conserving therapy (BCT), with some still opting for a mastectomy, according to research from The University of Texas MD Anderson Cancer Center.

4 Sep 2014

Oncolytics Biotech completes randomized Phase 2 study of ovarian, fallopian tube cancer

Oncolytics Biotech Inc. today announced that patient enrollment has been completed in a randomized Phase 2 study of paclitaxel plus REOLYSIN® versus paclitaxel alone in patients with persistent or recurrent ovarian, fallopian tube or primary peritoneal cancer (GOG186H).

4 Sep 2014

Mice who have partial deficiency of gene SENP2 are more likely to develop seizures, sudden death

A gene crucial for brain and heart development may also be associated with sudden unexplained death in epilepsy (SUDEP), the most common cause of early mortality in epilepsy patients.

4 Sep 2014

Leading experts propose new treatment guidelines for chronic Lyme disease

Current treatments for Lyme disease, particularly chronic forms of the disease, are inadequate, according to a new treatment guideline written by a group of leading experts.

4 Sep 2014

Novira completes Phase 1a clinical study of NVR-1221 for treatment of HBV infection

Novira Therapeutics, Inc., a privately held biopharmaceutical company developing novel therapies for curative treatment of chronic hepatitis B virus (HBV) infection, today announced successful completion of a Phase 1a clinical study of NVR-1221.

4 Sep 2014

Positive clinical data for first procedural therapy to treat type 2 diabetes from Fractyl

Fractyl Laboratories Inc. today announced positive clinical data for the first procedural therapy to directly treat the underlying digestive causes of insulin resistance in patients with uncontrolled type 2 diabetes.

4 Sep 2014

Doctor receives international patents for therapeutic process to remove excess galectin-3

Isaac Eliaz, MD, MS, LAc has been awarded a USA patent as well as additional international patents for a therapeutic process that allows for the removal of excess galectin-3 from the circulatory system using plasmapheresis.

4 Sep 2014

Study explores role of self-esteem and social adjustment in children and adolescents

In the current issue of Psychotherapy and Psychosomatics a Group of Greek investigators is reporting on a study exploring the role of self-esteem and social adjustment in children and adolescents.

4 Sep 2014

Research for better understanding of pathology of severe form of dwarfism

A better understanding of the pathology of a severe form of dwarfism as well as a possible window of treatment have been discovered by researchers at The University of Texas Health Science Center at Houston (UTHealth).

4 Sep 2014

Findings may help develop biomarkers to identify HIV patients at risk of dementia

Since the introduction of the combination anti-retroviral therapy (cART) in the mid-90s, the life expectancy of HIV patients has significantly improved. As a result, long-term complications are becoming more relevant: almost every second HIV patient is affected by neurocognitive disorders, which can lead to dementia.

4 Sep 2014

Nature of chemicals released into water became problem with air quality

Andrea Dietrich and Amanda Sain of Virginia Tech's Via Department of Civil and Environmental Engineering estimated that 50 percent of the population taste threshold for manganese II in water, the simplest ionic manganese oxide, to be more than 1000 times the current EPA allowable level.

4 Sep 2014

Stimulation therapy and behavioral management training for parents reduce kids’ violent behaviors

Prescribing both a stimulant and an antipsychotic drug to children with physical aggression and attention-deficit/hyperactivity disorder (ADHD), along with teaching parents to use behavior management techniques, reduces aggressive and serious behavioral problems in children, according to a study conducted by researchers in the Department of Psychiatry at Stony Brook University School of Medicine.

4 Sep 2014

Therapy News and Research

Viewpoints: Rove renews attack on health law; Calif. 'vaccination crisis'

Researchers demonstrate neuronal effects of novel treatment method for neurological diseases

Researchers investigating new ways to identify drugs against Ebola virus infection

Keytruda drug gets FDA approval for treatment of advanced melanoma

New actinic keratoses data presented at the 15th World Congress of Cancers of the Skin

Socio-economic barriers preclude patients from receiving breast conserving therapy

Oncolytics Biotech completes randomized Phase 2 study of ovarian, fallopian tube cancer

Mice who have partial deficiency of gene SENP2 are more likely to develop seizures, sudden death

Leading experts propose new treatment guidelines for chronic Lyme disease

Novira completes Phase 1a clinical study of NVR-1221 for treatment of HBV infection

Positive clinical data for first procedural therapy to treat type 2 diabetes from Fractyl

Doctor receives international patents for therapeutic process to remove excess galectin-3

Study explores role of self-esteem and social adjustment in children and adolescents

Research for better understanding of pathology of severe form of dwarfism

Findings may help develop biomarkers to identify HIV patients at risk of dementia

Nature of chemicals released into water became problem with air quality

Stimulation therapy and behavioral management training for parents reduce kids’ violent behaviors

Research to identify cancer-busting 'genetic partners' can personalize cancer treatment

Two week stay in specialized hospital may help manage insomnia

Treating wet AMD with gold nanoparticles: an interview with Jim Taylor, CEO, Oraya Therapeutics

Evaluating new approaches for rare disease genomics

Expanding access to NMR with the Fourier 80 Duo

Advancing Intracellular Delivery with LumiPore®

Latest News